Conference Reports for NATAP

64rd Annual Meeting of the American Association for the Study of Liver Diseases Washington, DC Nov 1-5 2013 Back

Vaniprevir (MK-7009) Demonstrates Higher Exposures in Treatment-Experienced Genotype (GT) 1 Cirrhotic Than Non-cirrhotic HCV-Infected Patients       Reported by Jules Levin AASLD 2013 Nov 1-5 Wash DC   Wei Gao, Luzelena Caro, Melanie Anderson, Peggy May Tan Hwang, Amy Zhou, Jing Su, Niloufar Mobashery Merck Research Laboratories, Merck & Co., Inc., Whitehouse, NJ